2-Pyridone-functionalized Aza-BODIPY photosensitizer for imaging-guided sustainable phototherapy
Source abstract
Abstract
To overcome irradiation-dependence of cancer phototherapy, a near infrared aza-BODIPY-based photothermogenic photosensitizer BDY with 2-Pyridone group has been synthesized for imaging-guided photothermal synergistic sustainable photodynamic therapy. Multifunctional water-soluble BDY nanoparticles (NPs), with high photothermal conversion efficiency of 35.7% and excellent singlet oxygen (1O2) generation ability, are prepared by self-assembling. The reversible transformation between 2-pyridone moiety and its endoperoxide form endows BDY with continuous 1O2 generation ability under illumination and non-illumination conditions. Simultaneously, BDY NPs exhibit excellent tumor targeting properties by enhanced permeability and retention (EPR) effect and photoacoustic imaging (PAI) ability. Furthermore, the photothermal assisted sustainable photodynamic therapy can significantly inhibit tumor growth (93.4% inhibition) with almost no side effects by intermittent laser illumination. The finding highlights that this photothermal synergistic sustainable phototherapy presents great potential for clinical applications.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine10.1021/ar7002804 ↗
2. Tumor-targeted small molecule for dual-modal imaging-guided phototherapy upon near-infrared excitation10.1039/C7TB02496G ↗
3. Activatable near infrared dye conjugated hyaluronic acid based nanoparticles as a targeted theranostic agent for enhanced fluorescence/CT/photoacoustic imaging guided photothermal therapy10.1016/j.biomaterials.2017.04.006 ↗
4. Mechanisms of growth inhibition of primary prostate epithelial cells following gamma irradiation or photodynamic therapy include senescence, necrosis, and autophagy, but not apoptosis10.1002/cam4.553 ↗
5. MoS2-Based multipurpose theranostic nanoplatform: realizing dual-imaging-guided combination phototherapy to eliminate solid tumor via a liquefaction necrosis process10.1039/C7TB02648J ↗
6. Oxygenic hybrid semiconducting nanoparticles for enhanced photodynamic therapy10.1021/acs.nanolett.7b04759 ↗
7. BODIPY-Mn nanoassemblies for accurate MRI and phototherapy of hypoxic cancer10.1039/C6TB02575G ↗
8. Light-activated hypoxia-responsive nanocarriers for enhanced anticancer therapy10.1002/adma.201505869 ↗
9. Nanozyme decorated metal–organic frameworks for enhanced photodynamic therapy10.1021/acsnano.7b07746 ↗
10. Regulating near-infrared photodynamic properties of semiconducting polymer nanotheranostics for optimized cancer therapy10.1021/acsnano.7b03507 ↗
11. Two-photon-excited near-infrared emissive carbon dots as multifunctional agents for fluorescence imaging and photothermal therapy10.1007/s12274-017-1528-0 ↗
12. Unity makes strength: how aggregation-induced emission luminogens advance the biomedical field
13. Mitochondrion-anchoring photosensitizer with aggregation-induced emission characteristics synergistically boosts the radiosensitivity of cancer cells to ionizing radiation10.1002/adma.201606167 ↗
14. Effects of visible light on the skin10.1111/j.1751-1097.2007.00286.x ↗
15. Deep tumor penetrating bioparticulates inspired burst intracellular drug release for precision chemo-phototherapy
16. Chemophototherapy: an emerging treatment option for solid tumors10.1002/advs.201600106 ↗
17. A step-by-step multiple stimuli-responsive nanoplatform for enhancing combined chemo-photodynamic therapy
18. Diketopyrrolopyrrole-based photosensitizers conjugated with chemotherapeutic agents for multimodal tumor therapy10.1021/acsami.7b09025 ↗
19. Advancing porphyrin's biomedical utility via supramolecular chemistry10.1039/C7CS00525C ↗
20. Synthesis and optimization of MoS2@Fe3O4-ICG/Pt(IV) nanoflowers for MR/IR/PA bioimaging and combined PTT/PDT/chemotherapy triggered by 808 nm laser10.1002/advs.201600540 ↗
21. Gold-nanosponge-based multistimuli-responsive drug vehicles for targeted chemo-photothermal therapy10.1002/adma.201602486 ↗
22. Hydrophobic binding peptide-conjugated hybrid lipid-mesoporous silica nanoparticles for effective chemo-photothermal therapy of pancreatic cancer10.1080/10717544.2017.1396382 ↗
23. The combination of chemotherapy and radiotherapy towards more efficient drug delivery10.1002/asia.201301294 ↗
24. Tumor microenvironment activable self-assembled DNA hybrids for pH and redox dual-responsive chemotherapy/PDT treatment of hepatocellular carcinoma10.1002/advs.201600460 ↗
25. Organotellurium and organoselenium compounds attenuate Mn-induced toxicity in caenorhabditis elegans by preventing oxidative stress10.1016/j.freeradbiomed.2012.02.044 ↗
26. BODIPY derivatives for photodynamic therapy: influence of configuration versus heavy atom effect10.1021/acsami.7b07569 ↗
27. Orthogonal BODIPY trimers as photosensitizers for photodynamic action10.1021/acs.orglett.6b02418 ↗
28. Light-driven transformable optical agent with adaptive functions for boosting cancer surgery outcomes10.1038/s41467-018-04222-8 ↗
29. Controlled oxygen release from pyridone endoperoxides promotes cell survival under anoxic conditions10.1021/jm4016137 ↗
30. Controlled release of singlet oxygen using diphenylanthracene functionalized polymer nanoparticles10.1039/c3cc48293f ↗
31. Base catalysed decomposition of anthracene endoperoxide10.1039/C5CC08606J ↗
32. A bifunctional photosensitizer for enhanced fractional photodynamic therapy: singlet oxygen generation in the presence and absence of light10.1002/anie.201511345 ↗
33. Generation, structure, and reactivity of o-iodobenzoyloxyl radicals. Pulsed laser photolysis of 1-(o-halobenzoyloxy)-2-pyridones10.1246/cl.2000.362 ↗
34. BODIPY dyes in photodynamic therapy10.1039/C2CS35216H ↗
35. An aza-BODIPY photosensitizer for photoacoustic and photothermal imaging guided dual modal cancer phototherapy10.1039/C6TB02979E ↗
36. pH-Triggered and enhanced simultaneous photodynamic and photothermal therapy guided by photoacoustic and photothermal imaging10.1021/acs.chemmater.7b01075 ↗
37. Polymer-encapsulated organic nanoparticles for fluorescence and photoacoustic imaging10.1039/C4CS00014E ↗
38. Near IR emitting red-shifting ratiometric fluorophores based on borondipyrromethene10.1021/acs.orglett.5b01299 ↗
39. Highly red-shifted NIR emission from a novel anthracene conjugated polymer backbone containing Pt(II) porphyrins10.1039/C5PY01473E ↗
40. The photostability and fluorescence properties of diphenylisobenzofuran10.1016/j.jlumin.2011.05.048 ↗
41. A fullerene-rhodamine B photosensitizer with pH-activated visible-light absorbance/fluorescence/photodynamic therapy10.1039/C8TB00372F ↗
42. NanoSOSG: a nanostructured fluorescent probe for the detection of intracellular singlet oxygen10.1002/anie.201609050 ↗
43. Organic dye based nanoparticles for cancer phototheranostics10.1002/smll.201704247 ↗
44. Diketopyrrolopyrrole-triphenylamine organic nanoparticles as multifunctional reagents for photoacoustic imaging-guided photodynamic/photothermal synergistic tumor therapy10.1021/acsnano.6b07927 ↗
45. MoO3-x quantum dots for photoacoustic imaging guided photothermal/photodynamic cancer treatment10.1039/C6NR09046J ↗
46. Molecular afterglow imaging with bright, biodegradable polymer nanoparticles10.1038/nbt.3987 ↗
47. Recent progress on semiconducting polymer nanoparticles for molecular imaging and cancer phototherapy10.1016/j.biomaterials.2017.11.025 ↗